The Evvy vaginal microbiome test promises to uncover all bacteria and fungi with a single swab and help women understand the results with a free one-to-one coaching call and action steps.
"Women weren't required to be in clinical research until 1993," says Priyanka Jain, who co-founded femtech start-up Evvy in 2021with Laine Bruzek, "And that lack of information leads us to the state of today that women are on average diagnosed four years later than men across over 700 diseases." To remedy this, Evvy was born and it uses DNA samples to detect specific types of bacteria in the vagina.
According to Jain, there are biomarkers that only exist in female bodies and many tend to go overlooked by both the medical and scientific communities. Evvy promises to help women avoid or deal with abnormal microbiome issues and help women experience better healthcare outcomes.
Intimate Care Microbiome Kits
The Evvy Vaginal Microbiome Test Detects Specific Types of Bacteria
Trend Themes
1. Microbiome Testing Kits - The market for at-home microbiome test kits is growing, providing opportunities for innovative startups to fill gaps in healthcare and empower individuals to take control of their health.
2. Femtech - The realm of female-focused health tech is expanding, with potential for innovations in intimate care that provide women with greater agency over their bodies.
3. Personalized Health Coaching - As the demand for personalized healthcare grows, there is an opportunity for startups to develop coaching platforms that cater to individual needs and help patients take a more proactive approach to wellness.
Industry Implications
1. Healthtech - The healthtech industry stands to benefit from the growing trend of personalized healthcare and the development of innovative technologies that empower patients to take control of their health.
2. Consumer Goods - As at-home health testing becomes more common, there is a potential opportunity for consumer goods companies to develop products that cater to individuals' specific microbiome needs, such as probiotics and other supplements.
3. Pharmaceuticals - As the field of microbiome research continues to grow, there is potential for pharmaceutical companies to develop targeted treatments for a variety of conditions that are influenced by the microbiome, such as yeast infections and bacterial vaginosis.